Skip to main content
. 2017 Mar 20;12(3):e0173592. doi: 10.1371/journal.pone.0173592

Table 2. Peak arterial enhancement (HU, mean ± standard deviation) for injection protocol A-D.

A B C D
right superior PA 430.7 ± 35.5 396.1 ± 30.1 596.2 ± 105.5 739.2 ± 135.9
right inferior PA 422.4 ± 24.1 394.9 ± 29.4 603.7 ± 90.5 743.9 ± 149.2
left superior PA 447.1 ± 65.6 389.4 ± 38.0 591.2 ± 74.7 674.8 ± 205.1
left inferior PA 441.3 ± 76.8 393.3 ± 55.5 602.8 ± 84.8 670.9 ± 205.8
ascending aorta 341.0 ± 33.7 350.4 ± 29.3 458.5 ± 71.7 497.1 ± 38.2
brachiocephalic trunk 371.3 ± 41.6 370.5 ± 33.4 454.0 ± 65.3 473.5 ± 51.1
descending aorta (mv) 356.2 ± 37.9 363.8 ± 38.8 460.8 ± 63.8 492.2 ± 56.8
descending aorta (d) 392.0 ± 40.5 372.6 ± 30.8 493.5 ± 66.6 525.6 ± 53.0
abdominal aorta (ct) 380.5 ± 36.7 360.2 ± 32.3 496.6 ± 74.2 497.9 ± 58.3
abdominal aorta (ra) 379.1 ± 47.1 370.0 ± 26.7 492.8 ± 86.9 474.2 ± 37.1
left renal artery 315.1 ± 61.3 322.0 ± 48.6 427.1 ± 85.9 414.8 ± 36.0
right renal artery 333.7 ± 50.7 343.2 ± 49.8 428.5 ± 85.9 445.2 ± 60.3

PA pulmonary artery; mv: level of mitral valve; d level of diaphragm (aortic hiatus); ct: level of celiac trunk; ra: level of renal arteries. All HU values are baseline corrected to avoid bias from residual intravasal CM from previous scans.